Related Experiment Video
Updated: May 14, 2025

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
NETs activate the GAS6-AXL-NLRP3 axis in macrophages to drive morphine tolerance
Qingyan Tian1, Haiyue Guo1, Mengyao Zhang1
1Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu, 211166, China.
Background:
The development of morphine tolerance presents a major clinical challenge in the effective management of severe pain. This study aims to explore the mechanisms underlying morphine tolerance from a novel perspective, with the ultimate goal of uncovering new insights and identifying promising therapeutic targets for its treatment.
Methods:
C57BL/6J mice were used in the tail-flick test to evaluate morphine tolerance. Neutrophils derived from mouse bone marrow were employed to investigate the mechanisms underlying morphine-induced NETs formation. Bone marrow-derived macrophages (BMDMs) were harvested from the femur and tibia to study the role of NETs-induced inflammation in analgesic tolerance. Proinflammatory cytokines were measured using Western blotting and real-time PCR. The levels of NETs and the TLR7/9-NLRP3-related signaling pathway were assessed through Western blotting, real-time PCR, and ELISA. Confocal laser scanning microscopy was utilized to visualize NETs in the dorsal root ganglion (DRG) and in cells.
Results:
Our experiments demonstrated that the levels of NETs in the plasma of patients using morphine for analgesia, as well as in morphine-tolerant animals, were significantly elevated. Genetic elimination of Pad4, neutrophil depletion, and treatment with DNase 1 and RNase A to disrupt NETs formation all effectively alleviated morphine tolerance. These findings indicate that NETs play a critical role in the development of morphine tolerance. Mechanistically, we discovered that morphine-induced NETs can be engulfed by macrophages through the GAS6-AXL axis, which subsequently triggers the activation of the TLR7/TLR9-mediated NLRP3 inflammasome, leading to significantly increased levels of IL-1β and IL-18, and ultimately contributing to tolerance. Deletion of Axl, Gas6, or Nlrp3 each significantly improved morphine tolerance. Furthermore, in the murine model, treatment with the IL-1 receptor antagonist anakinra and the IL-18 decoy receptor IL-18BP prevented the development of morphine tolerance.
Conclusions:
This study identifies morphine-induced NETs as a key contributor to morphine tolerance, with the GAS6-AXL-TLR7/9 axis emerging as a potential therapeutic target. Strategies focused on disrupting NETs and modulating this axis may offer a promising approach to combat morphine tolerance.
Insights
Neutrophil extracellular traps (NETs) drive morphine tolerance by activating the GAS6-AXL-TLR7/9 pathway. Disrupting NETs or this axis offers a novel strategy to manage pain effectively.
Area of Science:
- Immunology
- Pharmacology
- Pain Research
Background:
- Morphine tolerance is a significant clinical obstacle in managing severe pain.
- Understanding the molecular mechanisms of morphine tolerance is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the role of neutrophil extracellular traps (NETs) in the development of morphine tolerance.
- To elucidate the specific molecular pathways involved in NETs-mediated morphine tolerance.
- To identify potential therapeutic targets for combating morphine tolerance.
Main Methods:
- Evaluation of morphine tolerance in C57BL/6J mice using the tail-flick test.
- Investigation of NETs formation and macrophage engulfment via Western blotting, real-time PCR, ELISA, and confocal microscopy.
- Assessment of the GAS6-AXL-TLR7/9-NLRP3 inflammasome pathway and cytokine production (IL-1β, IL-18).
Main Results:
- Elevated NETs levels were observed in patients and animals experiencing morphine tolerance.
- Genetic or pharmacological disruption of NETs formation significantly alleviated morphine tolerance.
- Morphine-induced NETs are engulfed by macrophages via the GAS6-AXL axis, activating the TLR7/9-NLRP3 inflammasome and increasing IL-1β/IL-18, contributing to tolerance.
- Targeting components of this pathway (Axl, Gas6, Nlrp3) or using IL-1 receptor antagonist (anakinra) or IL-18BP ameliorated morphine tolerance.
Conclusions:
- Morphine-induced NETs are a critical factor in the development of analgesic tolerance.
- The GAS6-AXL-TLR7/9 signaling axis represents a novel therapeutic target for overcoming morphine tolerance.
- Interventions aimed at disrupting NETs or modulating this axis hold promise for improving pain management strategies.
Related Concept Videos
Analgesia and Pain Management
Opioid Receptors: Overview
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Nociception
GPCR Desensitization

